Unknown

Dataset Information

Inhibition of fatty acid synthase is protective in pulmonary hypertension.


ABSTRACT:

Background and purpose

In pulmonary hypertension (PH), similar to cancer, there is altered energy metabolism, apoptosis resistance and cellular proliferation leading to pulmonary vascular remodelling. Proliferating cells exhibit higher rate of de novo fatty acid synthesis to provide lipids for membrane formation and energy production. As inhibition of de novo fatty acid synthesis proved protective in cancer experimentally, therefore, it was hypothesized that modulation of de novo fatty acid synthesis by inhibition of fatty acid synthase (FAS) may prove beneficial for PH.

Experimental approach

For in vitro studies, human pulmonary artery smooth muscle cells (HPASMCs) were exposed to hypoxia and to induce PH in vivo, rats were treated with monocrotaline (MCT). FAS was inhibite

SUBMITTER: Singh N 

PROVIDER: S-EPMC4882492 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature